论文部分内容阅读
目的观察腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水的疗效与安全性。方法采用WLFHY 50 0型伟力电脑腹水超滤浓缩回输系统 ,对 2 3例肝硬变顽固性腹水患者行 2 9例次治疗 ,观察患者体重、腹围、2 4小时尿量及尿钠排出量、血肌酐、尿素氮、电解质、白蛋白等变化 ,随访 3个月以上 ,对疗效进行判定。结果经治疗后 ,患者 2 4小时尿量及尿钠增加 ,血清白蛋白水平增加 ;尿素氮、肌酐、电解质水平无显著性变化 ,总有效率达 6 5.5% ,无严重并发症。结论腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水 ,方法简便易行 ,且安全有效。
Objective To observe the efficacy and safety of ascites ultrafiltration concentration abdominal transfusion for the treatment of liver cirrhosis refractory ascites. Methods WLFHY 50 0 Weicheng computer ascites ultrafiltration concentrated infusion system, 23 cases of liver cirrhosis patients with refractory ascites 29 cases of treatment, patients were observed body weight, abdominal circumference, 24-hour urine output and urinary sodium excretion Volume, serum creatinine, urea nitrogen, electrolytes, albumin and other changes were followed up for more than 3 months to determine the efficacy. Results After treatment, the patients’ urinary output and urinary sodium increased 24 hours and the level of serum albumin increased. There was no significant change of urea nitrogen, creatinine and electrolytes, with the total effective rate reaching 6 5.5%, without serious complications. Conclusion Ascites ultrafiltration concentrated abdominal transfusion for the treatment of intractable ascites cirrhosis, the method is simple, safe and effective.